Executive Summary
Q1 2026 shows a challenging financial position for Alvio Labs, with a net loss of €4,226.52 and no recorded revenue during the period. The business is currently in a pre-revenue phase, investing in product development and operational infrastructure.
Key observations: Total assets have declined by 78.2% from March 2025 (€532.14 → €116.00), primarily due to cash burn on development activities. The balance sheet shows significant director loan accounts totaling €36,247.62, indicating substantial founder investment in the business.
⚠️ Critical Alert: The current cash position (€116) represents approximately 0.9 months of operating expenses at current burn rates. Immediate revenue generation or additional funding is recommended.
Q1 Net Profit
-€4,226.52
Loss widened from -€10,966.85 (CYE 2025)
Bank Balance (Revolut)
€116.00
Was €532.14 in March 2025
Total Assets
€116.00
Vs €532.14 in March 2025
Total Liabilities
€36,056.06
Was €14,948.99 in March 2025